[Leukotrienes and the lung]
- PMID: 6099600
[Leukotrienes and the lung]
Abstract
The implication of "slow reacting substance of Anaphylaxis" SRS-A in the pathogenesis of asthma was realised in 1950. In recent years SRS-A has been shown to be a mixture of varied composition: The Leukotrienes (LT) C4, D4 and E4. These substances derive their arachidonic acid through the 5-lipoxygenase. The LT B4, which is not conjugated to glutathione (as compared to LT C4, D4 and E4) possesses powerful chemotactic activity and an (indirect) contractile effect on smooth muscle. LTC4, D4, E4 in vitro and in vivo, both by inhalation or intravenously, are powerful bronchoconstrictors clearly superior to histamine. The effects of C4 and LTD4 predominantly affect the peripheral airways.
Similar articles
-
[Pharmacology of the leukotrienes].J Pharmacol. 1984;15 Suppl 1:53-68. J Pharmacol. 1984. PMID: 6328128 Review. French.
-
Leukotrienes and their possible significance for the pathogenesis of asthma.Allergol Immunopathol (Madr). 1985 Nov-Dec;13(6):531-7. Allergol Immunopathol (Madr). 1985. PMID: 3008545 Review.
-
The leukotrienes.Med Biol. 1984;62(4):215-30. Med Biol. 1984. PMID: 6096644 Review.
-
Leukotrienes: possible mediators in bronchial asthma.Eur J Respir Dis Suppl. 1983;129:45-64. Eur J Respir Dis Suppl. 1983. PMID: 6317422 Review.
-
[Leukotrienes].Sem Hop. 1984 Mar 29;60(14):979-85. Sem Hop. 1984. PMID: 6326287 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous